Paclitaxel and gemcitabine for refractory or relapsed small cell lung cancer (SCLC). A multicentric phase II study
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S62-S63
- https://doi.org/10.1016/s0959-8049(01)80712-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: